Xyz classification: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
m (Protected "Xyz classification" ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
== Leiomyosarcoma classification ==
__NOTOC__
__NOTOC__
{{Xyz}}
{{Xyz}}
Line 5: Line 4:
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}  
==Overview==
==Overview==
Leiomyosarcoma may be classified according to location of the tumor, prognosis and possible treatments into four group:
There is no established system for the classification of [disease name].
* Leiomyosarcoma of Soft Tissue Retroperitoneal Somatic soft tissue


*Leiomyosarcoma of Cutaneous Origin
OR
*Leiomyosarcoma of Vascular Origin (large vessel)
*Leiomyosarcoma in the Immunocompromised Host
*Leiomyosarcoma of Bone


While many staging systems exist for Leiomyosarcoma, the most commonly used system is the AJCC system.Leiomyosarcoma staging can also be done according to The Surgical Staging System of the Musculoskeletal Tumor Society (MSTS).Staging of leiomyosarcoma is important both in guiding treatment and in providing prognostic information.
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
 
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
 
OR
 
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
 
OR
 
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
 
OR
 
The staging of [malignancy name] is based on the [staging system].
 
OR
 
There is no established system for the staging of [malignancy name].


==Classification==
==Classification==


Leiomyosarcoma may be classified according to location of the tumor, prognosis and possible treatments into four group:
There is no established system for the classification of [disease name].
* Leiomyosarcoma of Soft Tissue Retroperitoneal Somatic soft tissue
 
OR
 
[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
*[Group1]
*[Group2]
*[Group3]
*[Group4]
 
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on:
*[Classification method 1]
*[Classification method 2]
*[Classification method 3]
 
[Disease name] may be classified into several subtypes based on:  
*[Classification method 1]
*[Classification method 2]
*[Classification method 3]
 
OR
 
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
 
OR
 
'''If the staging system involves specific and characteristic findings and features:'''


*Leiomyosarcoma of Cutaneous Origin
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
*Leiomyosarcoma of Vascular Origin (large vessel)
*Leiomyosarcoma in the Immunocompromised Host
*Leiomyosarcoma of Bone


== Staging ==
OR
Although many staging system exist for the soft tissue sarcoma but  the most commonly used system is the AJCC system.This system classifies the tumor based upon histological grade, the tumor size, location as superficial or deep, and the presence or absence of metastatic disease


{| class="wikitable"
The staging of [malignancy name] is based on the [staging system].
!Stage
!Histological Grade
!Size
!Location,


relative to fascia
OR
!Metastasis
|-
|IA
|Low
|< 5cm
|Superficial or Deep
|No
|-
|IB
|Low
|≥ 5cm
|Superficial
|No
|-
|IIA
|Low
|≥ 5cm
|Deep
|No
|-
|IIB
|High
|< 5cm
|Superficial or Deep
|No
|-
|IIC
|High
|≥ 5cm
|Superficial
|No
|-
|III
|High
|≥ 5cm
|Deep
|No
|-
|IV
|Any
|Any
|Any
|Yes
|}
Leiomyosarcoma staging can also be done according to The Surgical Staging System of the Musculoskeletal Tumor Society (MSTS).This staging system classifies tumors as Ia, Ib, IIa, IIb, or III based upon the histologic grade of the tumor, its local extent and the presence or absences of macroscopic distant metastatic disease. If the tumor is localized to a single anatomic compartment, it is said to be confined. If it has spread locally beyond its initial compartment, then it is said to be unconfined.


{| class="wikitable"
There is no established system for the staging of [malignancy name].
!Stage
!Histological
Grade
!Local Extent of Disease
!Metastasis
|-
|Ia
|Low
|Confined
|No
|-
|Ib
|Low
|Unconfined
|No
|-
|IIa
|High
|Confined
|No
|-
|IIb
|High
|Unconfined
|No
|-
|III
|Any
|Any
|Yes
|}


==References==
==References==
{{cite web |url=http://sarcomahelp.org/leiomyosarcoma.html |title=Leiomyosarcoma Cancer: Diagnosis, Treatment, Research & Support |format= |work= |accessdate=}}{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]
[[Category: (name of the system)]]

Latest revision as of 16:00, 22 November 2019

Xyz Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Xyz classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Xyz classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Xyz classification

CDC on Xyz classification

Xyz classification in the news

Blogs on Xyz classification

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Xyz classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There is no established system for the classification of [disease name].

OR

[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].

OR

[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].

OR

Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.

OR

If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].

OR

The staging of [malignancy name] is based on the [staging system].

OR

There is no established system for the staging of [malignancy name].

Classification

There is no established system for the classification of [disease name].

OR

[Disease name] may be classified according to [classification method] into [number] subtypes/groups:

  • [Group1]
  • [Group2]
  • [Group3]
  • [Group4]

OR

[Disease name] may be classified into [large number > 6] subtypes based on:

  • [Classification method 1]
  • [Classification method 2]
  • [Classification method 3]

[Disease name] may be classified into several subtypes based on:

  • [Classification method 1]
  • [Classification method 2]
  • [Classification method 3]

OR

Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.

OR

If the staging system involves specific and characteristic findings and features:

According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].

OR

The staging of [malignancy name] is based on the [staging system].

OR

There is no established system for the staging of [malignancy name].

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Xyz_classification&oldid=1589951"